Please login to the form below

Not currently logged in
Email:
Password:

emotive appoints new medical director

Dr Gill Boucher joins the agency from QuintilesIMS

emotive Dr Gill Boucheremotive has appointed Dr Gill Boucher as its new medical director in a role that also sees her join the London-based agency’s senior leadership team.

Dr Boucher arrives at emotive from QuintilesIMS, where she spent seven years, most recently working as product and strategy director developing medical communications.

A qualified physician, she began her career in the NHS before taking up a position with Martindale Pharmaceuticals, where she worked in medical affairs.

Chris Edmonds, emotive’s managing director, said: “Gill is a superb addition to emotive. and strengthens an extremely high calibre senior leadership team with backgrounds from HCP, agency and client-side.

“As emotive completes its transition to a fully fledged international healthcare communications agency with a strong heritage in leveraging technologies to stimulate engagement, Gill’s experience as a practicing physician and in various roles leading teams of medical directors and writers will ensure the agency continues to deliver high-quality scientific communications.“

In her new role at emotive Dr Boucher will oversee the agency’s in-house team of medical writers and provide senior strategic direction in all disciplines of medical communications.

9th March 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
TRIDUCIVE

Triducive are a strategic healthcare consultancy who produce communications that have practical, dynamic application that encourage behaviour change because of the...

Latest intelligence

Building the hospital of the future
Senior Consultant Leah Carlisle explores the growing trend of virtual hospitals and what it takes to develop a holistic digital ecosystem centered on the ultimate patient experience....
Why people join a clinical trial
To understand why people decide to take part in clinical trials, you first need to understand how people make decisions....
Article:
The disparity of patient experiences with Crohn’s Disease in Europe and Japan...